# A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants

> **NCT07219017** · PHASE1 · COMPLETED · sponsor: **AbbVie** · enrollment: 8 (actual)

## Conditions studied

- Healthy Volunteer

## Interventions

- **DRUG:** ABBV-1354

## Key facts

- **NCT ID:** NCT07219017
- **Lead sponsor:** AbbVie
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-10-15
- **Primary completion:** 2025-12-09
- **Final completion:** 2025-12-09
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2026-01-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07219017

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07219017, "A Study to Assess the Mass Balance of Oral ABBV-1354 in Healthy Adult Male Participants". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07219017. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*